What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His main research concerns Cell biology, Gap junction, Connexin, Pannexin and Hepatocyte.
Specifically, his work in Cell biology is concerned with the study of Cell signaling.
His Cell signaling study combines topics from a wide range of disciplines, such as Membrane potential and Pharmacology.
His biological study spans a wide range of topics, including Amino acid, Liver function, Cell growth and Pathology.
His work carried out in the field of Connexin brings together such families of science as Signal transduction and Calcium signaling.
His Hepatocyte research includes themes of Cell culture, Cancer therapy and In vivo.
His most cited work include:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (760 citations)
- Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 (416 citations)
- The adverse outcome pathway concept: A pragmatic tool in toxicology (230 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cell biology, Connexin, Gap junction, Pharmacology and Hepatocyte.
His Cell biology study deals with Cell growth intersecting with Cell cycle.
His Connexin research integrates issues from Cell signaling, Signal transduction and Neuroscience.
His research investigates the connection between Gap junction and topics such as Epigenetics that intersect with problems in DNA methylation and Histone.
The various areas that he examines in his Pharmacology study include In vitro and Cholestasis.
His studies examine the connections between Hepatocyte and genetics, as well as such issues in Trichostatin A, with regards to Histone deacetylase inhibitor, Molecular biology and Cancer research.
He most often published in these fields:
- Cell biology (33.08%)
- Connexin (24.06%)
- Gap junction (18.80%)
What were the highlights of his more recent work (between 2017-2021)?
- Cholestasis (8.65%)
- Adverse Outcome Pathway (11.65%)
- Pharmacology (18.05%)
In recent papers he was focusing on the following fields of study:
Mathieu Vinken focuses on Cholestasis, Adverse Outcome Pathway, Pharmacology, Connexin and Cell biology.
His research on Cholestasis also deals with topics like
- Liver injury which connect with In vivo,
- Bioinformatics which is related to area like In vitro toxicology.
As part of one scientific family, he deals mainly with the area of Pharmacology, narrowing it down to issues related to the In vitro, and often Pharmacology toxicology and Cell culture.
His Connexin study is concerned with the larger field of Gap junction.
His Gap junction research focuses on Extracellular and how it connects with Cytosol and Cell.
Mathieu Vinken works on Cell biology which deals in particular with Intracellular.
Between 2017 and 2021, his most popular works were:
- Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. (23 citations)
- Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report. (21 citations)
- TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice (20 citations)
In his most recent research, the most cited papers focused on:
Mathieu Vinken mainly focuses on Cholestasis, Pharmacology, Liver injury, Adverse Outcome Pathway and In vitro.
His Cholestasis research incorporates elements of Liver toxicity and Drug.
Mathieu Vinken studied Pharmacology and Gap junction that intersect with Hepatic stellate cell activation, Hepatic stellate cell and Cytosol.
Mathieu Vinken has researched Liver injury in several fields, including In vivo, Bile acid and Bioinformatics.
His work investigates the relationship between In vitro and topics such as Pharmacology toxicology that intersect with problems in In vitro system, Human hepatocyte, Hepatocyte and Consensus criteria.
Mathieu Vinken performs multidisciplinary study in the fields of Cell biology and Context via his papers.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
